Document:

Fifth Modification Agreement

 Exhibit 10.1 
 FIFTH MODIFICATION AGREEMENT TO BORROWING BASE REVOLVING 
 LINE OF CREDIT AGREEMENT 
  

					
	DATE:	  	As of November 6, 2007	  	
			
	PARTIES:	  		  	
		  	Borrower:	  	 WILLIAM LYON HOMES, INC., a
 California corporation

			
		  	Guarantor:	  	 WILLIAM LYON HOMES, a Delaware
 corporation

			
		  	Bank:	  	 JPMORGAN CHASE BANK, N.A.
 (successor by merger to
Bank One, NA
 (Main Office Chicago, Illinois)), a national
 banking association

 JPMORGAN CHASE BANK, N.A. (successor by merger to Bank One, NA (Main Office Chicago, Illinois)), a national
banking association (“Bank”), and WILLIAM LYON HOMES, INC., a California corporation (“Borrower”), hereby enter into this Fifth Modification Agreement to Borrowing Base Revolving Line of Credit Agreement (the
“Modification”) to the Borrowing Base Revolving Line of Credit Agreement dated as of June 28, 2004, as modified by a Modification Agreement, dated as of December 7, 2004, and as further modified by a Second Modification
Agreement to Borrowing Base Revolving Line of Credit Agreement, dated as of July 14, 2005, by a Third Modification Agreement to Borrowing Base Revolving Line of Credit Agreement, dated as of October 23, 2006, and by a Fourth Modification
Agreement to Borrowing Base Revolving Line of Credit Agreement, dated as of April 26, 2007 (the “Loan Agreement”), with the consent of guarantor WILLIAM LYON HOMES, a Delaware corporation (“Guarantor”).

 RECITALS 
 A. Bank has
extended to Borrower credit (“Loan”) up to the maximum principal amount of One Hundred Million Dollars ($100,000,000) pursuant to the Loan Agreement, as presently evidenced by that certain Amended and Restated Promissory Note dated
as of July 14, 2005 (the “Note”) executed by Borrower and payable to the order of Bank. 
 B. The Loan is secured by,
among other things, certain Construction Deeds of Trust and Fixture Filing (With Assignment of Rents and Security Agreement) executed by Borrower as Trustor for the benefit of Bank (such Deeds of Trust, as amended to dated, shall be hereinafter
referred to, individually, as a “Deed of Trust” and, collectively, as the “Deeds of Trust”). The Loan is further secured by the personal property described in certain UCC-1 Financing Statements relating to the
property encumbered by the Deeds of Trust naming Borrower as Debtor and Bank as Secured 

 
Party (as amended to date, the “UCC Financing Statements”). The Deeds of Trust, the UCC Financing Statements, and such other agreements,
documents and instruments securing the Loan are referred to individually and collectively as the “Security Documents”). 
 C. Repayment of the Loan has been, and continues to be, guaranteed by the Repayment Guaranty dated as of June 28, 2004 and executed by Guarantor in favor of Bank (the “Guaranty”). The Guaranty and any other agreements,
documents and instruments guarantying the Loan are referred to individually and collectively as the “Guaranty Documents”. 
 D. The Loan Agreement, the Note, the Security Documents, the Guaranty Documents, any environmental certification and indemnity agreement, and all other agreements, documents, and instruments evidencing, securing, or otherwise relating to
the Loan, as may be amended, modified, extended or restated from time to time, are sometimes referred to individually and collectively as the “Loan Documents”. Hereinafter, the Loan Documents shall mean such documents as modified in
this Modification. 
 E. The Borrower has requested that the Bank agree to extend the Revolving Credit Termination Date from June 28,
2008 to June 28, 2009, to extend the Maturity Date from June 28, 2009, to June 28, 2010, and to modify certain terms and conditions of the Loan Documents as hereinafter provided. Based on the representations of Borrower, Bank is
willing to so extend the Revolving Credit Termination Date and the Maturity Date and modify the Loan Documents, subject to the terms and conditions herein. 
 F. All capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in the Loan Agreement. 
 AGREEMENT 
 For good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Borrower and Bank agree as follows: 
  

	1.	ACCURACY OF RECITALS. 

 Borrower acknowledges the
accuracy of the Recitals. 
  

	2.	MODIFICATION OF LOAN DOCUMENTS. 

 2.1 The Revolving Credit
Termination Date is hereby extended from June 28, 2008 to June 28, 2009. In no event shall the Bank be required to make Advances of the Loan to Borrower and to issue Facility LCs for the account of Borrower after the Revolving Credit
Termination Date, as extended hereby. 
  

 2 

 2.2 The Maturity Date is hereby extended from June 28, 2009 to June 28, 2010. All principal,
interest and Other Amounts shall be immediately due and payable on the Maturity Date, as extended hereby. 
 2.3 Subparagraphs (e)(iv),
(e)(v) and (e)(vi) of the definition of “Maximum Allowed Advance” set forth in the Loan Agreement are is deleted in their entirety and replaced with the following: 
 “(iv) For each SFR Spec Unit, the lesser of (A) 80% of the lesser of (1) the Appraised Value for that Unit or (2) the current base
price at which Borrower is marketing such Unit, and (B) 90% of the Unit Cost for that Unit; 
 (v) For each Spec Unit which constitutes
an MFR Unit, the lesser of (A) 70% of the lesser of (1) the Appraised Value for that Unit or (2) the current base price at which Borrower is marketing such Unit, and (B) 85% of the Unit Cost for that Unit; 
 (vi) For each Spec Unit which constitutes a High Density Unit, the lesser of (A) 70% of the lesser of (1) the Appraised Value for that Unit or
(2) the current base price at which Borrower is marketing such Unit, and (B) 70% of the Unit Cost for that Unit;” 
 2.4
Section 3.3(b)(i) of the Loan Agreement is deleted in its entirety and replaced with the following: 
 “(i) Limitation on
Attached A&D Lot Availability in Approved Subdivisions. The aggregate Lot Collateral Value of all Attached A&D Lots (other than Attached A&D Lots that have been reclassified as Units) in all Approved Subdivisions included as Eligible
Collateral in the Borrowing Base may not exceed an amount equal to thirty percent (30%) of the Commitment Amount (the “Attached A&D Lot Sub-Limit”).” 
 2.5 Notwithstanding any provision in the Loan Agreement or in any other Loan Document to the contrary, the Model Units in the Approved Subdivision
commonly known as “Tramonto,” which was approved as an Approved Subdivision pursuant to that certain Project Loan Addendum dated as of October 7, 2005, may be included in the Borrowing Base as Eligible Collateral for a term of
thirty-six (36) Calendar Months from the original Unit Eligibility Date for such Model Units. 
 2.6 Notwithstanding any provision in
the Loan Agreement or in any other Loan Document to the contrary, the A&D Lots and the Model Units in the Approved Subdivision commonly known as “Groves at Falling Leaf,” which was approved as an Approved Subdivision pursuant to that
certain Project Loan Addendum dated as of May 24, 2006, may be included in the Borrowing Base as Eligible Collateral for a term of thirty-six (36) Calendar Months from the original Unit Eligibility Date for such A&D Lots and Model
Units. 
  

 3 

 2.7 The Mandatory Lot Commitment Reduction Schedule attached as Exhibit B to the Project Loan
Addendum dated as of May 24, 2006 for the Approved Subdivision commonly known as “Groves at Falling Leaf” is hereby amended and restated in it entirety by the Mandatory Lot Commitment Reduction Schedule attached hereto as Schedule
1. 
 2.8 Notwithstanding any provision in the Loan Agreement or in any other Loan Document to the contrary, the Model Units in the
Approved Subdivision commonly known as “Rancho Madrina,” which was approved as an Approved Subdivision pursuant to that certain Project Loan Addendum dated as of August 18, 2004, may be included in the Borrowing Base as Eligible
Collateral until June 19, 2008. 
 2.9 The Deeds of Trust are modified to secure payment and performance of the Loan as amended to date,
in addition to all other “Obligations” of Borrower as therein defined. The foregoing notwithstanding, certain obligations continue to be excluded from the Obligations, as provided in the Deeds of Trust. 
 2.10 Each of the Loan Documents is modified to provide that it shall be a default or an event of default thereunder if Borrower shall fail to comply with
any of the covenants of Borrower herein or if any representation or warranty by Borrower herein or by any guarantor in any related Consent and Agreement of Guarantor is materially incomplete, incorrect, or misleading as of the date hereof.

 2.11 Each reference in the Loan Documents to any of the Loan Documents shall be a reference to such document as modified herein.

  

	3.	RATIFICATION OF LOAN DOCUMENTS AND COLLATERAL. 

 The
Loan Documents are ratified and affirmed by Borrower and shall remain in full force and effect as modified herein. Any property or rights to or interests in property granted as security in the Loan Documents shall remain as security for the Loan and
the obligations of Borrower in the Loan Documents. 
  

	4.	CONDITIONS PRECEDENT. 

 Before this Agreement
becomes effective and any party becomes obligated under it, all of the following conditions shall have been satisfied at Borrower’s sole cost and expense in a manner acceptable to Bank in the exercise of Bank’s sole judgment: 

4.1 Bank shall have received fully executed and, where appropriate, acknowledged originals of this Modification, the attached consents signed by
Guarantor, and any other documents which Bank may require or request in accordance with this Agreement or the other Loan Documents. 
 4.2
Bank shall have received reimbursement, in immediately available funds, of all costs and expenses incurred by Bank in connection with this Agreement, including charges for title insurance (including endorsements), recording, filing and escrow
charges, fees for appraisal, architectural and engineering review, construction services 

  

 4 

 
and environmental services, mortgage taxes, and legal fees and expenses of Bank’s counsel. Such costs and expenses may include the allocated costs for
services of Bank’s in-house staffs, such as legal, appraisal, construction services and environmental services. Borrower acknowledges that any extension and modification fees payable in connection with this transaction do not include the
amounts payable by Borrower under this subsection. 
  

	5.	ENTIRE AGREEMENT, CHANGE, DISCHARGE, TERMINATION, OR WAIVER. 

 The Loan Documents as modified herein contain the entire understanding and agreement of Borrower and Bank in respect of the Loan and supersede all prior representations, warranties, agreements, arrangements, and
understandings. No provision of the Loan Documents as modified herein may be changed, discharged, supplemented, terminated, or waived except in a writing signed by Bank and Borrower. 
  

	6.	BINDING EFFECT. 

 The Loan Documents as modified
herein shall be binding upon, and inure to the benefit of, Borrower and Bank and their respective successors and assigns. 
  

	7.	CHOICE OF LAW. 

 This Agreement shall be governed by
and construed in accordance with the laws of the State of California, without giving effect to conflicts of law principles. 
  

	8.	COUNTERPART EXECUTION. 

 This Agreement may be
executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same document. Signature pages may be detached from the counterparts and attached to a single copy of this
Agreement to physically form one document. 
 [Signatures on following page] 
  

 5 

 DATED as of the date first above stated. 
  

									
	BORROWER:	 		 	 WILLIAM LYON HOMES, INC.,
 a California
corporation

					
		 		 		 	By:	 	 
		 		 		 	Name: 	 	 
		 		 		 	Title: 	 	 
					
		 		 		 	By:	 	 
		 		 		 	Name: 	 	 
		 		 		 	Title: 	 	 
			
	BANK:	 		 	JPMORGAN CHASE BANK, N.A. (successor by merger to Bank One, NA (Main Office Chicago, Illinois)), a national banking association
					
		 		 		 	By:	 	 
		 		 		 	Name: 	 	 
		 		 		 	Title: 	 	 

  

 6 

 CONSENT AND AGREEMENT OF GUARANTOR 
 With respect to that certain Fifth Modification Agreement to the Borrowing Base Revolving Line of Credit Agreement (hereinafter, the
“Modification”) between WILLIAM LYON HOMES, INC., a California corporation (“Borrower”), and JPMORGAN CHASE BANK, N.A. (successor by merger to Bank One, NA (Main Office Chicago, Illinois)), a national banking
association (“Bank”), to which this Consent is attached, the undersigned (“Guarantor”), hereby (i) ratifies and reaffirms all of its obligations to Bank under the Guaranty, (ii) consents to the execution
and delivery by Borrower of the attached Modification, and (iii) confirms that the Guaranty remains in full force and effect notwithstanding Borrower’s execution of the attached Modification. The undersigned agrees that the execution of
this Consent and Reaffirmation of Guarantor (the “Consent”) is not necessary for the continued validity and enforceability of the Guaranty, but it is executed to induce Bank to enter into the Modification Agreement. 
 This Consent may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and
the same document. Signature pages may be detached from the counterparts and attached to a single copy of this Consent to physically form one document. Facsimile transmission of the signed original of this Consent or the retransmission of any signed
facsimile transmission will be deemed the same as delivery of an original. 
 IN WITNESS WHEREOF, Guarantor has executed this Agreement as of
the date set forth on the attached Fifth Modification Agreement. 
  

									
	“Guarantor”	 		 	 WILLIAM LYON HOMES,
 a Delaware corporation

					
		 		 		 	By:	 	 
		 		 		 	Name: 	 	 
		 		 		 	Title: 	 	 
					
		 		 		 	By:	 	 
		 		 		 	Name: 	 	 
		 		 		 	Title: 	 	 

  

 7 

 SCHEDULE 1 
 Mandatory Lot Commitment Reduction Schedule 
 (Groves at Falling Leaf) 
  

															
	Total Lots	  	88	 		  		  		  		 	
	Total Lot Commitment / MAA per lot	  	$7,260,000	 	$82,500.00/Lot	  		  		  		 	
	Reductions Start At End Of Month >>	  	15	 	Final Quarterly Reduction At End Of Month >>	 	36
	Appraised Absorption /
 Required Qtrly Takedown (80% Appr.
Abs.)
	  	12	 	10.00	  	$825,000	  	(Par Quarterly
Reduction
Amount)	 	
	Appraised Bulk Value	  	$9,680,000	 	$110,000/Lot	  	Total Cost:	  	$10,404,680	 	$118,235/Lot
							
	 	  	 	  	 	 	 	  	 	  	 	  	 Maximum
 Advance Rates

	End Of
Month	  	 Development &
 Marketing
 Period
	  	% Of Par
Release Price	 	Reduction
Amount/Qtr	  	 Lot
 Sub-Commit.
	  	Maximum
Lots With
Availability	  	LTV	 	LTC
	15	  	Unit Construction & Closings Continue (10/31/07)	  	0%	 	$0	  	$7,260,000	  	88	  	75%	 	70%
	18	  	Unit Construction & Closings Continue (01/31/08)	  	125%	 	$1,031,250	  	$6,228,750	  	78	  	73%	 	68%
	21	  	Unit Construction & Closings Continue (04/30/08)	  	125%	 	$1,031,250	  	$5,197,500	  	68	  	69%	 	65%
	24	  	Unit Construction & Closings Continue (07/31/08)	  	125%	 	$1,031,250	  	$4,166,250	  	58	  	65%	 	61%
	27	  	Unit Construction & Closings Continue (10/31/08)	  	125%	 	$1,031,250	  	$3.135,000	  	48	  	59%	 	55%
	30	  	Unit Construction & Closings Continue (01/31/09)	  	125%	 	$1,031,250	  	$2,103,750	  	38	  	50%	 	47%
	33	  	Unit Construction & Closings Continue (04/30/09)	  	125%	 	$1,031,250	  	$1,072,500	  	28	  	35%	 	32%
	36	  	Project Close-Out (07/31/09)	  	130%	 	$1,072,500	  	$0	  	0	  	0%	 	0%

  

 SCHEDULE 1Executive Severance Benefits Agreement - Edward F. Schnipper, M.D.

 Exhibit 10.1 
 EXECUTIVE SEVERANCE BENEFITS AGREEMENT 
 This EXECUTIVE SEVERANCE
BENEFITS AGREEMENT (the “Agreement”) is entered into this 26th day of November, 2007 (the “Effective Date”), between EDWARD F.
SCHNIPPER, M.D. (“Executive”) and NOVACEA, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits
described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6. 
 The
Company and Executive hereby agree as follows: 
 ARTICLE 1. 
 SCOPE OF AND CONSIDERATION FOR THIS AGREEMENT 
 1.1 Position and
Duties. Effective November 26, 2007, Executive shall be employed by the Company as Chief Medical Officer and will report directly to the Chief Executive Officer of the Company (“CEO”). 
 1.2 Restrictions. During his employment by the Company, Executive agrees to the best of his ability and experience that he will at all
times loyally and conscientiously perform all of the duties and obligations required of and from him as Chief Medical Officer of the Company. During the term of his employment, except as otherwise permitted under the Company’s corporate
governance, employment or other applicable policies, Executive further agrees that (i) he will devote substantially all of his business time and attention to the business of the Company, (ii) the Company will be entitled to all of the
benefits and profits arising from or incident to all work, services and advice performed for or on behalf of the Company, (iii) Executive will not render commercial or professional services of any nature to any person or organization that
interferes with Executive’s ability to carry out his duties as Chief Medical Officer of the Company, whether or not for compensation, without the prior written consent of the Board, and (iv) Executive will not directly or indirectly engage
or participate in any business that is competitive in any manner with the business of the Company without the prior written consent of the Board. Nothing in this Agreement will prevent Executive from accepting speaking or presentation engagements in
exchange for honoraria or from service on boards of charitable organizations or otherwise participating in civic, charitable or fraternal organizations, or from owning no more than one percent (1%) of the outstanding equity securities of a
corporation whose stock is listed on a national stock exchange. 
 1.3 Patent, Copyright and Nondisclosure Agreement. Executive
acknowledges and agrees that he has previously executed and delivered, or on the date hereof will execute and deliver, to an officer of the Company the Company’s Patent, Copyright and Nondisclosure Agreement (the “Nondisclosure
Agreement”). 
 1.4 Confidentiality of Terms. Executive agrees to follow the Company’s strict policy that
employees must not disclose, either directly or indirectly, any information that has not been disclosed by the Company, including any of the terms of this Agreement, regarding salary, bonuses, or stock purchase or option allocations to any person,
including other employees of the Company; provided, however, that Executive may discuss such terms with members of his 

 
immediate family and any legal, tax or accounting specialists who provide Executive with individual legal, tax or accounting advice, and Executive may
discuss such terms with other employees of the Company on a need to know basis if required to carry out Executive’s duties as Chief Medical Officer of the Company or at the request of the Board. 
 1.5 Benefits Upon Change of Control and Employment Termination. The Company and Executive wish to set forth the compensation and benefits
which Executive shall be entitled to receive in the event of a Change of Control or if Executive’s employment with the Company is terminated under the circumstances described herein. 
 1.6 Consideration. The duties and obligations of the Company to Executive under this Agreement shall be in consideration for
Executive’s employment with the Company, the duties and obligations of Executive to the Company under this Agreement, including under the Nondisclosure Agreement, and Executive’s execution of a release in accordance with Section 5.1
hereof. 
 1.7 Prior Agreement. This Agreement shall supersede any other agreement, whether written or oral, relating to
severance benefits in the event of Executive’s severance from employment. 
 ARTICLE 2. 
 OPTION ACCELERATION 
 2.1
Change of Control Option Acceleration. In the event of a Change of Control, the vesting and/or exercisability of Executive’s Stock Awards shall be accelerated automatically immediately prior to the effective date of such Change of
Control as to fifty percent (50%) of the unvested shares subject to such Stock Awards. For the avoidance of doubt, the fifty percent (50%) of shares subject to acceleration of vesting described in this Section 2.1 shall be limited to
the portion of Executive’s outstanding Stock Awards that is unvested as of the date of the accelerated vesting. 
 2.2 Option
Acceleration Upon Covered Termination In Connection with Change of Control. In the event of a Covered Termination of Executive’s employment during a Change of Control Benefits Period, the vesting and/or exercisablity of each of
Executive’s outstanding Stock Awards shall be accelerated automatically immediately prior to the effective date of the Change of Control as to 100% of the shares subject to the Stock Award. 
 ARTICLE 3. 
 SEVERANCE BENEFITS 

 3.1 Severance Benefits. A Covered Termination of Executive’s employment that occurs other than during a Change of
Control Benefits Period entitles Executive to receive the benefits set forth in this Section 3.1. 
 (a) Base
Salary. The Company shall pay to Executive an amount equal to twelve (12) months’ Base Salary. Subject to Section 3.3 hereof, the severance amount contemplated by this Section 3.1(a) shall be paid over the twelve (12)-month
period commencing on the date of termination in equal monthly installments and shall be subject to all required tax and other applicable withholding. 
  

 2 

 (b) Bonus. The Company shall pay to Executive an amount equal to the sum of
(i) any earned (without regard to whether Executive was employed on the date of payment), but unpaid bonus for the fiscal year preceding the fiscal year during which the Covered Termination occurs, (ii) an amount equal to one hundred
percent (100%) of Executive’s target annual bonus for the fiscal year during which the Covered Termination occurs, prorated to reflect the actual period of service completed by Executive during the fiscal year through the date of
termination, and (iii) an amount equal to fifty percent (50%) of Executive’s target annual bonus for the fiscal year during which the Covered Termination occurs, with such bonus determined based on deemed achievement of all of the
performance objectives for such fiscal year. Subject to Section 3.3 hereof, the amounts contemplated by Sections 3.1(b)(i) and (ii) shall be paid in cash in a lump sum within thirty (30) days following the date of termination and
shall be subject to all required tax and other applicable withholding. Subject to Section 3.3 hereof, the severance benefits contemplated by this Section 3.1(b)(iii) shall be paid in cash over the six (6)-month period commencing on the
date of termination in equal monthly installments and shall be subject to all required tax and other applicable withholding. 
 3.2
Change of Control Severance Benefits. A Covered Termination of Executive’s employment during a Change of Control Benefits Period entitles Executive to receive the benefits set forth in this Section 3.2. 
 (a) Base Salary. The Company shall pay to Executive an amount equal to twelve (12) months’ Base Salary. Subject to
Section 3.3 hereof, the severance benefit contemplated by this Section 3.2(a) shall be paid in cash in a lump sum within thirty (30) days following the Covered Termination and shall be subject to all required tax and other applicable
withholding. 
 (b) Bonus. The Company shall pay to Executive an amount equal to the sum of (i) any earned
(without regard to whether Executive was employed on the date of payment), but unpaid bonus for the fiscal year preceding the fiscal year during which the Covered Termination occurs, (ii) an amount equal to one hundred percent (100%) of
Executive’s target annual bonus for the fiscal year during which the Covered Termination occurs, prorated to reflect the actual period of service completed by Executive during the fiscal year through the date of termination, and (iii) an
amount equal to fifty percent (50%) of Executive’s target annual bonus for the fiscal year during which the Covered Termination occurs, with such bonus determined based on deemed achievement of all of the performance objectives for such
fiscal year. Subject to Section 3.3 hereof, the severance benefits contemplated by this Section 3.2(b) shall be paid in cash in a lump sum within thirty (30) days following the Covered Termination and shall be subject to all required
tax and other applicable withholding. 
 (c) No Duplication of Benefits. The payments and benefits provided for
in this Section 3.2 shall only be payable in the event of a Covered Termination of Executive’s employment during a Change of Control Benefits Period. In the event of a Covered Termination of Executive’s employment other than during a
Change Control Benefits Period, then Executive shall receive the payments and benefits described in Section 3.1 hereof and shall not be eligible to receive any of the payments and benefits described in this Section 3.2. 
  

 3 

 3.3 Timing of Payments. The payments contemplated in Sections 3.1 and 3.3 hereof shall be
paid at such times as are provided therein; provided, however, that, in the event that Executive is considered a “Specified Employee” as defined in proposed or final Treasury Regulations promulgated under Section 409A
(“Section 409A”) of the Code, and payments under Sections 3.1 or 3.2 hereof are considered “deferred compensation” under Section 409A, the payment shall be delayed for six months, in which event Executive shall
receive on the first business day that is at least six months and one day after the date of termination a lump sum equal to all payments otherwise due during such six month period pursuant to Sections 3.1 and 3.2 hereof, along with interest at a
floating rate equal to LIBOR from the date such payments were otherwise due to the date of payment. 
 3.4 Other Terminations.
If Executive’s employment is terminated by the Company for Cause, by Executive other than pursuant to a Constructive Termination or as a result of Executive’s death or disability, the Company shall not have any other or further obligations
to Executive under this Agreement (including any financial obligations) except that Executive shall be entitled to receive (a) Executive’s fully earned but unpaid base salary, through the date of termination at the rate then in effect, and
(b) all other amounts or benefits to which Executive is entitled under any compensation, retirement or benefit plan or practice of the Company at the time of termination in accordance with the terms of such plans or practices, including,
without limitation, any continuation of benefits required by federal COBRA law or applicable law. In addition, subject to the provisions of the Company’s equity compensation plans and the terms of Executive’s Stock Awards, if
Executive’s employment is terminated by the Company for Cause, by Executive other than pursuant to a Constructive Termination or as a result of Executive’s death or disability, all vesting of Executive’s unvested Stock Awards
previously granted to him by the Company shall cease and none of such unvested Stock Awards shall be exercisable following the date of such termination. The foregoing shall be in addition to, and not in lieu of, any and all other rights and remedies
that may be available to the Company under the circumstances, whether at law or in equity. 
 3.5 Mitigation. Except as
otherwise specifically provided herein, Executive shall not be required to mitigate damages or the amount of any payment provided under this Agreement by seeking other employment or otherwise, nor shall the amount of any payment provided for under
this Agreement be reduced by any compensation earned by Executive as a result of employment by another employer or by any retirement benefits received by Executive after the date of the Covered Termination. 
 3.6 Exclusive Remedy. Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein or in the
Company’s equity compensation plans and the terms of Executive’s Stock Awards, all of Executive’s rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination of Executive’s
employment shall cease upon such termination. In the event of a termination of Executive’s employment with the Company, Executive’s sole remedy shall be to receive the payments and benefits described in this Agreement. 
  

 4 

 ARTICLE 4. 
 RESTRICTIVE COVENANTS 
 4.1 Non-Solicitation. In further consideration of the duties
and obligations of the Company to Executive hereunder, Executive acknowledges that during the course of his employment with the Company, Executive will become familiar with the Company’s trade secrets and with other confidential information
concerning the Company and that Executive’s services shall be of special, unique and extraordinary value to the Company; and, therefore, Executive agrees that, during the one-year period commencing on the date of termination of Executive’s
employment for any reason (the “Restricted Period”), Executive shall not, directly or indirectly, through another person or entity, (i) induce, solicit, encourage or attempt to induce, solicit or encourage any employee of the
Company to leave the employ of the Company, or in any way interfere with the relationship between the Company and any employee thereof; or (ii) induce, solicit or encourage or attempt to induce, solicit or encourage any customer, supplier,
licensee, licensor, franchisee or other business relation of the Company to cease doing business with the Company, or in any way interfere with the relationship between any such customer, supplier, licensee or business relation of the Company.

 4.2 Modification of Covenants. If, at the time of enforcement of any of the covenants contained in Section 4.1 hereof,
a court of competent jurisdiction shall hold that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such
circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum period, scope and area permitted by law. 
 ARTICLE 5. 
 LIMITATIONS AND
CONDITIONS ON BENEFITS 
 5.1 Release Prior to Payment of Benefits. Upon the occurrence of a Covered Termination of
Executive’s employment, and prior to the payment of any benefits under this Agreement on account of such Covered Termination, Executive shall execute a release (the “Release”) in the form attached hereto and incorporated herein
as Exhibit A or Exhibit B, as applicable. Such Release shall specifically relate to all of Executive’s rights and claims in existence at the time of such execution and shall confirm Executive’s obligations under the Nondisclosure
Agreement. It is understood that, as specified in the applicable Release, Executive has a certain number of calendar days to consider whether to execute such Release, and Executive may revoke such Release within seven (7) calendar days after
execution. In the event Executive does not execute such Release within the applicable period, or if Executive revokes such Release within the subsequent seven (7) day period, no benefits shall be payable under this Agreement. 
 5.2 Termination of Benefits. Benefits under this Agreement shall terminate immediately if Executive, at any time, violates any proprietary
information or confidentiality obligation to the Company, including, without limitation, the Nondisclosure Agreement. 
  

 5 

 ARTICLE 6. 
 DEFINITIONS 
 For purposes of the Agreement, the following terms are defined as follows: 

6.1 “Base Salary” means Executive’s annual base salary as in effect during the last regularly scheduled payroll period
immediately preceding the Covered Termination. 
 6.2 “Board” means the Board of Directors of the Company.

 6.3 “Cause” means that, in the reasonable determination of the Company, Executive: 
 (a) has committed an act of fraud or embezzlement or has intentionally committed some other illegal act that has a material adverse
impact on the Company or any successor or parent or subsidiary thereof; 
 (b) has been convicted of, or entered a plea
of “guilty” or “no contest” to, a felony which causes or may reasonably be expected to cause substantial economic injury to or substantial injury to the reputation of the Company or any subsidiary or affiliate of the Company;

 (c) has made any unauthorized use or disclosure of confidential information or trade secrets of the Company or any
successor or parent or subsidiary thereof that has a material adverse impact on any such entity; 
 (d) has committed
any other intentional misconduct that has a material adverse impact on the Company or any successor or parent or subsidiary thereof, or 
 (e) has intentionally refused or intentionally failed to act in accordance with any lawful and proper direction or order of the Board or the appropriate individual to whom Executive reports, provided such
direction is not materially inconsistent with Executive’s customary duties and responsibilities. 
 6.4 “Change of
Control” means and includes each of the following: 
 (a) the acquisition, directly or indirectly, by any
“person” or “group” (as those terms are defined in Sections 3(a)(9), 13(d) and 14(d) of the Exchange Act) of “beneficial ownership” (as determined pursuant to Rule 13d-3 under the Exchange Act) of securities
entitled to vote generally in the election of directors (“voting securities”) of the Company that represent fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities,
other than: 
 (i) an acquisition by a trustee or other fiduciary holding securities under any employee benefit plan
(or related trust) sponsored or maintained by the Company or any person controlled by the Company or by any employee benefit plan (or related trust) sponsored or maintained by the Company or any person controlled by the Company, or 
  

 6 

 (ii) an acquisition of voting securities by the Company or a corporation owned,
directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of the stock of the Company; 
 Notwithstanding the foregoing, the following event shall not constitute an “acquisition” by any person or group for purposes of this Section: an acquisition of the Company’s securities by the Company
that causes the Company’s voting securities beneficially owned by a person or group to represent fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities; provided, however,
that if a person or group shall become the beneficial owner of fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities by reason of share acquisitions by the Company as described above
and shall, after such share acquisitions by the Company, become the beneficial owner of any additional voting securities of the Company, then such acquisition shall constitute a Change of Control; or 
 (b) During any period of two consecutive years, individuals who, at the beginning of such period, constitute the Board together
with any new director(s) (other than a director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in Section 6.4(a) or Section 6.4(c)) whose election by the Board or
nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or whose election or nomination for
election was previously so approved, cease for any reason to constitute a majority thereof; or 
 (c) the consummation
by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of
all or substantially all of the Company’s assets in a single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in each case other than a transaction: 
 (i) which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent
(either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all
of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor
Entity’s outstanding voting securities immediately after the transaction, and 
 (ii) after which no person or
group beneficially owns voting securities representing fifty percent (50%) or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this clause (ii) as
beneficially owning fifty percent (50%) or more of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction; or 
  

 7 

 (d) the Company’s stockholders approve a liquidation or dissolution of the
Company. 
 Notwithstanding the foregoing, a transaction shall not constitute a Change of Control if: (i) it constitutes the
Company’s initial public offering of its securities; or (ii) it is a transaction effected primarily for the purpose of financing the Company with cash (as determined by the Board in its discretion and without regard to whether such
transaction is effectuated by a merger, equity financing or otherwise). The Board shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change of Control of the Company has occurred
pursuant to the above definition, and the date of the occurrence of such Change of Control and any incidental matters relating thereto. 
 6.5 “Change of Control Benefits Period” means the period commencing on the
180th day immediately preceding the effective date of a Change of Control and ending the last day of the 12-month period following the Change of Control.

 6.6 “Code” means the Internal Revenue Code of 1986, as amended from time to time and the Treasury
Regulations thereunder. 
 6.7 “Company” means Novacea, Inc., a Delaware corporation, or, following a Change of
Control, the surviving entity resulting from such transaction. 
 6.8 “Constructive Termination” means that Executive
voluntarily terminates employment after any of the following are undertaken without Executive’s express written consent: 
 (a) the removal of or a material reduction in the nature or scope of Executive’s responsibilities, or the assignment to Executive of duties that are materially inconsistent with Executive’s position other than a change in
reporting relationship; 
 (b) a change in Executive’s direct reporting relationship so that Executive no longer
reports directly to the CEO; 
 (c) a reduction in Executive’s base salary; 
 (d) a reduction in Executive’s target bonus; or 
 (e) a relocation of Executive’s place of employment by more than thirty (30) miles from such Executive’s place of
employment on the Effective Date. 
 The termination of Executive’s employment as a result of Executive’s death or disability will
not be deemed to be a Constructive Termination. 
 6.9 “Covered Termination” means an Involuntary Termination Without
Cause or a Constructive Termination. 
 6.10 “Exchange Act” means the Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder. 
  

 8 

 6.11 “Involuntary Termination Without Cause” means Executive’s dismissal or
discharge other than for Cause. The termination of Executive’s employment as a result of Executive’s death or disability will not be deemed to be an Involuntary Termination Without Cause. 
 6.12 “Stock Awards” means all stock options, restricted stock and such other awards granted pursuant to the Company’s stock
option and equity incentive award plans or agreements and any shares of stock issued upon exercise thereof. 
 ARTICLE 7. 

GENERAL PROVISIONS 
 7.1
Employment Status. This Agreement does not constitute a contract of employment or impose upon Executive any obligation to remain as an employee, or impose on the Company any obligation (a) to retain Executive as an employee, (b) to
change the status of Executive as an at-will employee, or (c) to change the Company’s policies regarding termination of employment. 
 7.2 Notices. Any notices provided hereunder must be in writing, and such notices or any other written communication shall be deemed effective upon the earlier of personal delivery (including personal delivery by facsimile) or
the third day after mailing by first class mail to the Company at its primary office location and to Executive at Executive’s address as listed in the Company’s payroll records. Any payments made by the Company to Executive under the terms
of this Agreement shall be delivered to Executive either in person or at the address as listed in the Company’s payroll records. 
 7.3 Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal
or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and
enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. 
 7.4
Waiver. If either party should waive any breach of any provisions of this Agreement, he or it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. 
 7.5 Arbitration. Any dispute, claim or controversy based on, arising out of or relating to Executive’s employment or this Agreement
shall be settled by final and binding arbitration in San Mateo County, California, before a single neutral arbitrator in accordance with the National Rules for the Resolution of Employment Disputes (the “Rules”) of the American
Arbitration Association, and judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction. Arbitration may be compelled pursuant to the California Arbitration Act (Code of Civil Procedure §§ 1280
et seq.). If the parties are unable to agree upon an arbitrator, one shall be appointed by the AAA in accordance with its Rules. Each party shall 

  

 9 

 
pay the fees of its own attorneys, the expenses of its witnesses and all other expenses connected with presenting its case; however, Executive and the
Company agree that, to the extent permitted by law, the arbitrator may, in his discretion, award reasonable attorneys’ fees to the prevailing party. Other costs of the arbitration, including the cost of any record or transcripts of the
arbitration, AAA’s administrative fees, the fee of the arbitrator, and all other fees and costs, shall be borne by the Company. This Section 7.5 is intended to be the exclusive method for resolving any and all claims by the parties against
each other for payment of damages under this Agreement or relating to Executive’s employment; provided, however, that neither this Agreement nor the submission to arbitration shall limit the parties’ right to seek provisional
relief, including, without limitation, injunctive relief, in any court of competent jurisdiction pursuant to California Code of Civil Procedure § 1281.8 or any similar statute of an applicable jurisdiction. Seeking any such relief shall not be
deemed to be a waiver of such party’s right to compel arbitration. Both Executive and the Company expressly waive their right to a jury trial. Pursuant to California Civil Code Section 1717, each party warrants that it was represented by
counsel in the negotiation and execution of this Agreement, including the attorneys’ fees provision herein. 
 7.6 Complete
Agreement. This Agreement, including Exhibit A and Exhibit B, constitutes the entire agreement between Executive and the Company and is the complete, final, and exclusive embodiment of their agreement with regard to this subject
matter, wholly superseding all written and oral agreements with respect to severance benefits to Executive in the event of employment termination. It is entered into without reliance on any promise or representation other than those expressly
contained herein. Notwithstanding anything herein to the contrary, this Agreement shall not supersede any indemnification agreement between Executive and the Company. 
 7.7 Amendment or Termination of Agreement. This Agreement may be changed or terminated only upon the mutual written consent of the Company and Executive. The written consent of the Company to a change or
termination of this Agreement must be signed by an executive officer of the Company after such change or termination has been approved by the Board. 
 7.8 Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the
same Agreement. 
 7.9 Headings. The headings of the Articles and Sections hereof are inserted for convenience only and shall
not be deemed to constitute a part hereof nor to affect the meaning thereof. 
 7.10 Successors and Assigns. This Agreement is
intended to bind and inure to the benefit of and be enforceable by Executive, and the Company, and any surviving entity resulting from a Change of Control and upon any other person who is a successor by merger, acquisition, consolidation or
otherwise to the business formerly carried on by the Company, and their respective successors, assigns, heirs, executors and administrators, without regard to whether or not such person actively assumes any rights or duties hereunder; provided,
however, that Executive may not assign any duties hereunder and may not assign any rights hereunder without the written consent of the Company, which consent shall not be withheld unreasonably. 
  

 10 

 7.11 Choice of Law. All questions concerning the construction, validity and interpretation
of this Agreement will be governed by the law of the State of California, without regard to such state’s conflict of laws rules. 
 7.12 Non-Publication. The parties mutually agree not to disclose publicly the terms of this Agreement except to the extent that disclosure is mandated by applicable law or regulation or to their respective advisors (e.g.,
attorneys, accountants). 
 7.13 Construction of Agreement. In the event of a conflict between the text of the Agreement and
any summary, description or other information regarding the Agreement, the text of the Agreement shall control. 
 7.14 Code
Section 409A. The parties acknowledge and agree that, to the extent applicable, this Agreement shall be interpreted in accordance with, and the parties agree to use their best efforts to achieve timely compliance with, Section 409A,
and the Department of Treasury Regulations and other interpretive guidance issued thereunder, including, without limitation, any such regulations or other guidance that may be issued after the Effective Date. Notwithstanding any provision of this
Agreement to the contrary, in the event that the Company determines that any amounts payable hereunder would otherwise be taxable to Executive under Section 409A, the Company may adopt such limited amendments to this Agreement and appropriate
policies and procedures, including amendments and policies with retroactive effect, that the Company reasonably determines are necessary or appropriate to comply with the requirements of Section 409A and thereby avoid the application of penalty
taxes under such Section. 
 (SIGNATURE PAGE FOLLOWS) 
  

 11 

 IN WITNESS WHEREOF, the parties have executed this
Agreement on the Effective Date written above. 
  

									
	NOVACEA, INC.	 		 	EDWARD F. SCHNIPPER, M.D.
				
	By:	 	/s/ John P. Walker	 		 	/s/ Edward F. Schnipper, M.D.
	Name:	 	 John P. Walker
	 		 		 	
	Title:	 	 CEO
	 		 		 	

 Exhibit A: Release (Individual Termination) 
 Exhibit B: Release (Group Termination) 
  

 12 

 EXHIBIT A 
 RELEASE 
 (INDIVIDUAL TERMINATION)

 Certain capitalized terms used in this Release are defined in the Executive Severance Benefits Agreement (the
“Agreement”) which I have executed and of which this Release is a part. 
 I hereby confirm my obligations under the
Company’s Patent, Copyright and Nondisclosure Agreement. 
 I acknowledge that I have read and understand Section 1542 of the
California Civil Code which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have
materially affected his or her settlement with the debtor.” I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims I may
have against the Company. 
 Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its
parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys fees, damages,
indemnities and obligations of every kind and nature, in law, equity, or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action
against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands
directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including but not limited to, claims of intentional and negligent infliction of emotional distress, any and all
tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other
form of disputed compensation; claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1866 and 1867; Title VII of the Civil Rights Act of 1964, as amended; the federal
Civil Rights and Women’s Equity Act of 1991; Sections 1981 through 1988 of Title 42 of the Unites States Code, as amended; the federal Occupational Safety and Health Act of 1970; the Consolidated Omnibus Budge Reconciliation Act of 1985; the
federal Family and Medical Leave Act of 1992; the Federal Worker Adjustment and Retraining Notification Act of 1988; the federal Vocational Rehabilitation Act of 1973; the federal Equal Pay Act of 1963; the federal Fair Labor Standards Act; the
National Labor Relations Act, as amended; the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”); the federal Employee Retirement Income Security Act of 1974, as amended; the federal Americans with
Disabilities Act of 1990; the California Fair Employment and Housing Act, as amended; the California 

  

 1 

 
Workers’ Compensation Act; the California Unruh and Ralph Civil Rights Act; the California Alcohol and Drug Rehabilitation Law; the California Equal Pay
Law; tort law; contract law; statutory law; common law; wrongful discharge; discrimination; fraud; defamation; emotional distress; and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this
paragraph shall be construed in any way to release the Company from its obligation to indemnify me pursuant to the Company’s indemnification obligation pursuant to agreement or applicable law. 
 I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under ADEA. I also acknowledge that the consideration given
under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that:
(A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney of my choice prior to executing this Release; (C) I have
twenty-one (21) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following the execution of this Release by the parties to revoke the Release; and
(E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth day after this Release is executed by me. I hereby understand that the revocation contemplated in this paragraph
shall not be effective unless it is in writing and signed by me and received by the Company prior to the expiration of the revocation period. I further acknowledge that I have read this Release carefully and completely understand each of the terms
of this Release. 
  

			
	EDWARD F. SCHNIPPER, M.D.
		
	Date:	 	  

  

 2 

 EXHIBIT B 
 RELEASE 
 (GROUP TERMINATION) 
 Certain capitalized terms used in this Release are defined in the Executive Severance Benefits Agreement (the “Agreement”) which I have
executed and of which this Release is a part. 
 I hereby confirm my obligations under the Company’s Patent, Copyright and Nondisclosure
Agreement. 
 I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: “A
general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the
debtor.” I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims I may have against the Company. 
 Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their
officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys fees, damages, indemnities and obligations of
every kind and nature, in law, equity, or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment
with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or
in any way connected with my employment with the Company or the termination of that employment, including but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims
or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of disputed compensation; claims
pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1866 and 1867; Title VII of the Civil Rights Act of 1964, as amended; the federal Civil Rights and Women’s Equity Act
of 1991; Sections 1981 through 1988 of Title 42 of the Unites States Code, as amended; the federal Occupational Safety and Health Act of 1970; the Consolidated Omnibus Budge Reconciliation Act of 1985; the federal Family and Medical Leave Act of
1992; the Federal Worker Adjustment and Retraining Notification Act of 1988; the federal Vocational Rehabilitation Act of 1973; the federal Equal Pay Act of 1963; the federal Fair Labor Standards Act; the National Labor Relations Act, as amended;
the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”); the federal Employee Retirement Income Security Act of 1974, as amended; the federal Americans with Disabilities Act of 1990; the California Fair Employment and
Housing Act, as amended; the California 

  

 1 

 
Workers’ Compensation Act; the California Unruh and Ralph Civil Rights Act; the California Alcohol and Drug Rehabilitation Law; the California Equal Pay
Law; tort law; contract law; statutory law; common law; wrongful discharge; discrimination; fraud; defamation; emotional distress; and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph
shall be construed in any way to release the Company from its obligation to indemnify me pursuant to the Company’s indemnification obligation pursuant to agreement or applicable law. 
 I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under ADEA. I also acknowledge that the consideration given
under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that:
(A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney of my choice prior to executing this Release; (C) I have
forty-five (45) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following the execution of this Release by the parties to revoke the Release; (E) this
Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth day after this Release is executed by me. I hereby understand that the revocation contemplated in this paragraph shall not be
effective unless it is in writing and signed by me and received by the Company prior to the expiration of the revocation period. I further acknowledge that I have read this Release carefully and completely understand each of the terms of this
Release; and, as required by ADEA, that I have received with this Release a detailed list of the job titles and ages of all employees who were terminated in this group termination and the ages of all employees of the Company in the same job
classification or organizational unit who were not terminated. 
  

			
	EDWARD F. SCHNIPPER, M.D.
		
	Date:	 	  

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]